Phase 1 clinical trial
Scope
Date
~
-
Construction
Doosan Enerbility wins combined cycle power plant order in Kazakhstan
Doosan Enerbility Co., a South Korean power plant builder, announced on Wednesday that it has signed a contract with Turkestan LLP, a subsidiary of ...
Mar 15, 2023 (Gmt+09:00)
-
Supply chain
Samsung SDS acquires Korea’s No. 1 procurement SCM company
Samsung SDS Co., the information technology service unit of South Korea's Samsung Group, has acquired a 33.39% stake in Emro Inc., Korea's top suppl...
Mar 15, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korean biotech NKMax’s unit aims for US IPO
NKMax Co., a South Korean cancer drug maker, is in talks with local and foreign investors in a bid to list its California-based unit NKGen Biotech I...
Mar 14, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
CGBio opens cosmetic surgery clinic in Bali using bio-medical tech
CGBio, a South Korean bio-renewable medical company, announced on Monday that it opened a medical esthetic clinic, called Nulook, in Bali, Indonesia...
Mar 14, 2023 (Gmt+09:00)
-
Automobiles
Hyundai to boost India presence via takeover of GM plant
Hyundai Motor Co., the leading South Korean carmaker, is set to expand its presence in India with a takeover of General Motors Co.’s plant in ...
Mar 13, 2023 (Gmt+09:00)
-
Electronics
Samsung's Neo QLED selected as Best Gaming TV by Consumer Reports
Samsung Electronics Co.'s Neo QLED was recently awarded "Best Gaming TV" by Consumer Reports, a leading American consumer magazine. The magazine tes...
Mar 13, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Timeline of HYBE's failed bid for SM vs Kakao
(All dates in 2023) -- Jan. 15: Align Partners Capital Management filed proxy litigation against SM Entertainment Co. Founder Lee Soo-man and seven...
Mar 12, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
HYBE withdraws bid for SM in $1 bn battle with Kakao
South Korea's HYBE Co., the company behind the global sensation BTS, said on Sunday it has decided to pull out of the face-off with Kakao Corp. for ...
Mar 12, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Square’s Swiss unit joins EU quantum satellite project
A Swiss company owned by South Korea’s SK Square Co. has joined a European project to develop a quantum communications satellite, the company ...
Mar 09, 2023 (Gmt+09:00)
-
Corporate governance
POSCO Engineering & Construction renames itself POSCO E&C
POSCO Engineering & Construction, the builder affiliate of South Korea's POSCO Group, has changed its name to "POSCO E&C" to mark the first ...
Mar 09, 2023 (Gmt+09:00)
-
Foreign exchange
Korea won sees largest drop in 1 month on hawkish Powell
The South Korean won currency on Wednesday suffered its largest depreciation in more than a month as Federal Reserve Chairman Jerome Powell signal...
Mar 08, 2023 (Gmt+09:00)
-
Upcoming IPOs
Korea’s sole foreign clinic operator CHA Healthcare to go public in 2025
CHA Healthcare Co. operating nearly 90 hospitals and infertility treatment centers across the world, is set to pave the way for South Koreans' inves...
Mar 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit receives $1 mn in tech fees from Guardant Health of US
The US operations of South Korea's artificial intelligence (AI) medical company Lunit have received a major boost after the company got the green li...
Mar 08, 2023 (Gmt+09:00)
-
Retail
S.Korean fashion brands rush to China for pent-up demand
South Korean fashion brands are poised to expand their stores in China, aiming to capture pent-up demand in the world’s top consumer market af...
Mar 07, 2023 (Gmt+09:00)
-
Robotics
Korea's SK Telecom jointly develops AI patrol robots
SK Telecom Co., along with its partner firms, will develop artificial intelligence (AI) robots that will replace security guards patrolling around s...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Construction
Daewoo E&C completes Algerian power plant project amid pandemic
Daewoo Engineering & Construction Co., one of South Korea’s leading builders, said on Friday that it has completed an $830 million gas-fir...
Mar 03, 2023 (Gmt+09:00)
-
Batteries
SK IE Technology mulls adding LiBS factory in US, says SKIET president
SK IE Technology Co. (SKIET), a global top lithium-ion battery separator (LiBS) player under South Korea’s energy and battery maker SK Innovat...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials
Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...
Feb 28, 2023 (Gmt+09:00)
-
Korean startups
FADU joins ranks of unicorns as S.Korea’s first fabless chip firm
FADU Technology has become South Korea’s first fabless semiconductor unicorn after successfully raising funds from share sales before its init...
Feb 28, 2023 (Gmt+09:00)
-
Artificial intelligence
Hyundai Elevator cuts breakdowns with AI prediction technology
South Korea’s No. 1 elevator maker Hyundai Elevator Co. said on Monday it had reduced the number of stoppages and breakdowns of its elevators ...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Jetema applies to test its botulinum toxin in US from July
South Korea's bio-esthetic pharmaceutical company Jetema Co. will hold clinical trials in the US to advance to the American market, the world's bigg...
Feb 27, 2023 (Gmt+09:00)
-
Batteries
Korean firms scurry to expand nickel, lithium supply chains
South Korea’s leading companies such as SK, POSCO, LG and LX are scurrying to expand their supply chains for lithium and nickel, key raw mater...
Feb 24, 2023 (Gmt+09:00)
-
Central bank
BOK holds rates as it lowers growth, inflation forecasts
South Korea’s central bank held its policy interest rate unchanged on Thursday as it slashed forecasts for economic growth and inflation altho...
Feb 23, 2023 (Gmt+09:00)
-
Artificial intelligence
Naver, Creverse sign agreement for hyperscale AI education cooperation
Naver Corp., South Korea's largest search engine company, has signed an agreement with Creverse Co., an education company, to provide support for el...
Feb 23, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea to spur defense sector tech with $1.5 bn R&D investment
South Korea plans to accelerate growth in the defense industry, a future growth engine of Asia’s fourth-largest economy, by investing more tha...
Feb 23, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom, NTT Docomo jointly publish technical white paper
SK Telecom Co. announced on Wednesday that it had published a technical white paper on 6G common requirements and 5G base station power-saving measu...
Feb 23, 2023 (Gmt+09:00)
Latest News
- 1 Xiaomi to open first offline store in S.Korea with premium products
- 2 Loss-making Lotte Chemical to sell water treatment unit to Synopex
- 3 Google to invest $100 mn in Gentle Monster in smart glasses push
- 4 Growth equity portfolio largely shielded from policy headwinds: Summit
- 5 Naver Financial seeks to acquire S. Korean real estate data platform Asil